Category 6 - PATHOLOGY SERVICES
73301 - Additional Information
Item Start Date:
01-Aug-2020
Description Updated:
01-Sep-2022
Schedule Fee Updated:
01-Aug-2020
Group
P7 - Genetics
A test of tumour tissue from a patient with advanced (FIGO III-IV), high grade serous or high grade epithelial ovarian, fallopian tube or primary peritoneal cancer, requested by a specialist or consultant physician, to determine eligibility relating to BRCA status for access to treatment with a poly (adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor under the Pharmaceutical Benefits Scheme (PBS)
Applicable once per primary tumour diagnosis
Fee: $1,200.00 Benefit: 75% = $900.00 85% = $1,101.30
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change